Abstract: Angiotensin II (Ang II) might induce pro-inflammatory effects directly in the vascular wall independently of its haemodynamic effects. The aim of our study was to investigate the putative direct pro-inflammatory and vasomotor effects of Ang II and compare to those of lipopolysaccharides (LPS) in mouse isolated mesenteric resistance-sized arteries (MRA) supported by experiments in cultured human primary endothelial and vascular smooth muscle cells. Results showed that 24-hr organ culture of mouse MRA with 10 nM Ang II had, unlike 100 ng/mL LPS, no effects on IL-6 or MCP-1 secretion, VCAM1 mRNA expression or endothelial function, while Ang II significantly decreased maximal vasomotor responses to phenylephrine. In support, 24-hr organ culture of mouse MRA significantly suppressed Agtr1a mRNA and augmented Tlr4 mRNA along with attenuated vasomotor responses to Ang II. Moreover, contrary to LPS and TNF-a, Ang II and [Sar1]-Ang II had no concentration-or time-dependent effects on IL-6 and MCP-1 secretion in human umbilical vein endothelial cells (HUVEC) and human aortic smooth muscle cells (HASMC). AGTR1 or AGTR2 mRNA expression was undetectable in HUVEC, whereas HASMC expressed only AGTR1 mRNA. In summary, contrary to previous studies and the observed effects of LPS, we could not demonstrate direct vascular pro-inflammatory effects of Ang II ex vivo or in vitro. As indicated by our results, down-regulation or desensitization of AT 1 R during culture may explain our findings.
Vascular inflammation is increasingly recognized as a key feature in the pathophysiology of a range of cardiovascular diseases and associated risk factors [1, 2] . Signalling via the transcription factor nuclear factor-kappaB (NF-jB) plays a central role in controlling the process of vascular inflammation. Activation of NF-jB induces expression of inflammatory mediators, such as interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) and vascular adhesion molecule-1 (VCAM-1), which may impair endothelial function and enhance vascular reactivity [3] . Lipopolysaccharides (LPS) via Toll-like receptor 4 (TLR4) and tumour necrosis factor-a (TNF-a) via TNF receptor 1 are considered prototypical NF-jB activators [4] . Interestingly, both agents have been shown to play a role in the pathogenesis of hypertension [5, 6] and atherosclerosis [7, 8] .
Angiotensin II (Ang II), the key effector peptide of the renin-angiotensin II-aldosterone system (RAAS), is a powerful vasoconstrictor and an essential mediator in the regulation of cardiovascular homeostasis. Ang II mediates its effects predominantly via activation of the Ang II type 1 receptor (AT 1 R) in human beings and AT 1A R and AT 1B R in mice and rats, while the function of AT 2 R is unresolved [9] . In addition to its physiological roles, Ang II can induce vascular injury by facilitating pro-inflammatory responses with subsequent vascular remodelling and endothelial dysfunction [10] . Changes in the vascular structure and function of especially small resistance arteries are known to increase the risk of hypertension-related complications [2] . Interestingly, clinical studies suggest that Ang II may exert detrimental effects on the vascular wall independently of its haemodynamic influences [10] . Blocking the AT 1 R pharmacologically reduced inflammation and vascular injury in hypertensive patients [11, 12] , effects that were independent of blood pressure reduction. While in vivo models can be limited by complexity and difficulties in isolating direct vascular responses, in vitro studies offer the advantage of better control of experimental conditions. In support of the clinical findings, in vitro studies have shown direct pro-inflammatory effects of Ang II in cultured endothelial cells (EC) [13, 14] and vascular smooth muscle cells (VSMC) [15] [16] [17] , although with controversial findings in VSMC by Jiang et al. [18] . Investigations of cultured intact artery segments are, on the other hand, limited to a few studies in mouse aortae and carotid arteries [19, 20] . This is despite the advantages that organ culture provides compared to cell culture, which is a more physiologically relevant environment with the architecture of the vessel wall preserved and the possibility of investigating vascular function in addition to molecular and biochemical characteristics. To our knowledge, no attempts of studying the direct pro-inflammatory effects of Ang II in mouse isolated resistance-sized arteries have been made, despite the significance of small resistance arteries in hypertension-related complications. The aim of our study was therefore to investigate pro-inflammatory and vasomotor effects of Ang II ex vivo in mouse isolated mesenteric resistance-sized arteries (MRA) alongside the prototypical pro-inflammatory inducer, LPS. In support of and to further elucidate our findings in mouse isolated MRA, we investigated pro-inflammatory effects of Ang II in mouse isolated aorta segments and in cultured human primary EC and VSMC.
Materials and Methods
Chemicals and solutions. Dulbecco's modified Eagle's medium (DMEM) was purchased from Biological Industries. Endothelial cell growth medium 2 (ECGM2) including SupplementMix was from PromoCell. Medium 231, smooth muscle growth supplement, penicillin/streptomycin (pen/strep) and FBS were from Gibco, Thermo Fisher Scientific (Waltham, MA, USA). Monoclonal antibody against VCAM-1 (MAB6434) was obtained from R&D Systems, while antieNOS (610296) was from BD Transduction Laboratories and anti-beta actin (ab6276) was from Abcam. AlphaLISA immunoassay kits for mouse IL-6 (AL504C), mouse CCL2/MCP1 (AL509C), human IL-6 (AL223C) and human CCL2/MCP1 (AL244C) and AlphaScreen SureFire NF-jB p65 p-Ser536 assay kit (TGRNFS500) were purchased from PerkinElmer. All other chemicals were obtained from Sigma Aldrich. LPS was from Escherichia coli O26:B6 with a potency of 3,000,000 EU/mg. Preparations of Ang II and [Sar1]-Ang II were tested negative for endotoxin contamination.
Physiological salt solution (PSS) was of the following composition (in mM): NaCl 119, NaHCO 3 25, KCl 4.7, KH 2 PO4 1.18, MgSO 4 Á7H 2 O 1.17, CaCl 2 Á2H 2 O 1.5, ethylene diamine tetraacetic acid (EDTA) 0.027 and glucose 5.5 (with pH adjusted to 7.4). K-PSS was prepared by replacing all sodium with an equimolar amount of potassium resulting in a total K + concentration of 125 mM. Ca 2+ -free PSS was similar to PSS except that CaCl 2 was replaced by 0.01 mM ethylene glycol-bis(2-aminoethyl ether)-N,N,N′N′-tetraacetic acid (EGTA).
Animals and human donors. All animal procedures were performed strictly within national laws and guidelines. The investigations conformed to the Guide for the Care and Use of Laboratory Animals and the EU Directive 2010/63/EU for animal experiments. Male C57BL/6NTac mice (25-30 g ) from Taconic, Denmark, were housed in our local animal facilities on standard 12-hr light and 12-hr dark cycle conditions in a temperature-and humidity-controlled environment with access to standard chow and water ad libitum.
Two voluntary healthy adult male individuals donated surgically removed gluteal fat biopsies to the study after having given informed consent (Ethics Committee Protocol No. H-2-2014-019). The work described was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).
Artery preparation and organ culture. All mice were killed by cervical dislocation prior to exsanguination. The mesenteric arcade and aorta were excised immediately after killing and immersed in icecold PSS (see composition above). Artery segments were isolated as previously described [21] .
For the organ culture studies, segments of mouse aorta and secondorder MRA were divided into four groups. The first group of vessels was either mounted on myographs or snap-frozen for molecular studies immediately after dissection (Fresh). The three other groups were incubated in cell culture dishes for 24 hr in DMEM supplemented with pen/strep (100 U/mL and 100 lg/mL), L-glutamine (2 mM) and FBS (10%) at 37°C in humidified air containing 5% CO 2 with either 100 ng/mL LPS (LPS), 10 nM (unless stated otherwise) Ang II [19] (Ang II) or in the absence of LPS or Ang II (Ctr).
Vasomotor responses. Segments (~2 mm long) of mouse MRA and human subcutaneous resistance arteries (SRA) were mounted, normalized and tested for viability in the wire myograph (DMT, Denmark) as previously described [21] , except that human SRA were mounted on 40-lm-diameter wires. Vasomotor responses of mouse MRA segments to cumulatively increasing (half-log increments) concentrations of phenylephrine (PE, 1 nM-10 lM) and Ang II (100 pM-1 lM) were determined. K-PSS was applied between the cumulative concentration-response curves to reduce desensitization [22] . At the end of the experiments, the maximal contractile responses of the vessels (DT max ) were determined by measuring the difference in vessel wall tension (DN/m) when the vessels were maximally contracted with 'cocktail' solution (10 lM PGF 2a and 10 lM 5-HT in K-PSS) and when maximally relaxed in Ca 2+ -free PSS (see composition above). The intrinsic tone (basal stretch-induced tone) was determined as the difference in vessel wall tension when held in PSS and Ca 2+ -free PSS. Endothelial function of the MRA segments was assessed by the vasodilation mediated by 10 lM carbachol on top of a stable precontraction induced by 3-10 lM noradrenaline or PE (corresponding to about 80% of the maximal response of the individual artery segment to the adrenergic agonist) as previously described [21] .
For each artery segment, concentration-response curves were analysed using GraphPad Prism 6.07 software (GraphPAD Corp., San Diego, CA, USA). PE-mediated responses were analysed with iterative nonlinear regression as previously described [23] , while Ang II-mediated responses were analysed as maximal responses between 10 and 100 nM and by using area under the curve (AUC). Vessel responses were expressed as either active vessel wall tension (DT, N/m), percentage of the maximal contractile response of the vessels (% of DT max ) or percentage vasodilation from a steady pre-contraction tone (% vasodilation).
Vasomotor responses of human SRA segments to cumulatively increasing concentrations of Ang II and the degradation-resistant analogue [Sar1]-Ang II (100 pM-100 nM) were determined. Responses were expressed as percentage of K-PSS responses (% of K-PSS).
Western blotting. Aorta segments were snap-frozen on dry ice and stored at À80°C. Artery segments were placed in RIPA lysis buffer (Alpha Diagnostics; 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1.0 mM EDTA, 1.0% (v/v) NP-40, 0.5% (w/v) sodium deoxycholate, 0.1% SDS, 0.01% (w/v) sodium azide) at a ratio of 60 ll buffer pr. mg tissue (wet weight). The tissue samples were homogenized using Tissuelyser II (Qiagen, Hilden Germany) with a 5-mm stainless steel bead for 2 min. by 25 Hz at 4°C. The solution was cleared by 10-min. centrifugation at 20,000 9 g at 4°C. Protein was quantified in the extracts by BCA protein assay kit (Thermo Fisher Scientific). Aliquots containing 10-20 lg of protein were resolved in 4-12% BisTris gels (Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, USA) and transferred to nitrocellulose membranes for 7 min. using the iBlot â system (Invitrogen, Thermo Fisher Scientific). Membranes were blocked in 5% skim milk in TBS-T (Tris-buffered saline containing 0.1% Tween-20; Amresco Inc., Solon, Ohio, USA) and subsequently incubated overnight at 4°C with primary antibodies diluted in 5% skim milk in TBS-T (VCAM-1, 1:1000; eNOS, 1:250). As a loading control, the membranes were probed for beta actin (1:10,000). Membranes incubated with HRP-conjugated secondary antibodies diluted in 5% skim milk in TBS-T were developed using the Lumigen â TMA-6 Enhanced Chemiluminescence Advance
Western Blot Detection Kit (GE Healthcare Lifesciences, Chicago, USA). Protein bands were quantified by densitometry using the NIH Image J software [24] . Data presented are normalized to b-actin. IL-6 and MCP-1 protein measurements. Incubation media from organ and cell culture experiments were frozen at À80°C. Samples from organ culture experiments were diluted 1:10 in DMEM. The AlphaLISA immunoassays (PerkinElmer) were used according to the manufacturer's instructions. The sample analyte concentrations were calculated using standard curves in GraphPad Prism software (GraphPAD Prism 6.07; GraphPAD Corp., San Diego, CA, USA).
RNA extraction and RT-qPCR. Mesenteric resistance-sized arteries segments were snap-frozen on dry ice and stored at À80°C for subsequent analysis. Tissue samples were homogenized in Buffer RLT (Qiagen) using the Tissuelyser II (Qiagen) with a 5-mm stainless steel bead for 2 9 2 min. by 25 Hz at 4°C. The solution was cleared by 3-min. centrifugation at 26,000 9 g at room temperature. Cells were harvested in Buffer RLT (Qiagen) supplemented with 1% bmercaptoethanol and lysates were stored at À80°C. Total RNA was purified with the RNeasy technology (Qiagen) according to the manufacturer's instructions. Single-stranded cDNA synthesis by reverse transcription of total RNA was performed according to the manufacturer's recommendations (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, Thermo Fisher Scientific).
After cDNA synthesis, quantitative real-time PCR (qPCR) was performed in the QuantStudio 12K Flex system (Applied Biosystems, Thermo Fisher Scientific). qPCR for mouse Vcam1, Nos3 (eNOS), Agtr1a, Agtr1b, Agtr2 and Tlr4 along with human IL-6, CCL2 (MCP-1), NOS3 (eNOS), VCAM1, AGTR1, AGTR2 and TLR4 was performed using Taqman gene expression assays (Vcam1: Mm01320970_m1; Nos3: Mm00435217_m1; Agtr1a: Mm00616371_ m1; Agtr1b: Mm01701115_m1; Agtr2: Mm01341373_m1; Tlr4: Mm00445273_m1; IL-6: Hs00985639_m1; CCL2: Hs00234140_m1; NOS3: Hs01574659_m1; VCAM1: Hs01003372_m1; AGTR1: Hs00 258938_m1; AGTR2: Hs00169126_m1; TLR4: Hs00152939_m1; Thermo Fisher Scientific). Samples were run in duplicate, and data were analysed using the 2 ÀDDCt method with beta-2 microglobulin (B2m: Mm00437762_m1) and hypoxanthine phosphoribosyltransferase 1 (HPRT1; Hs02800695_m1) serving as reference genes in mouse and human samples, respectively. Data are presented as fold change relative to the indicated control shown as mean including range of expression. Range was calculated by incorporating the standard deviation of the DDC T values into the fold change calculations as previously described [26] . Statistical analysis was performed on DC T values.
Statistical analysis. Results are presented as mean AE S.E.M. (n = the number of artery segments or the number of passages and N = the number of animals) except for RT-qPCR results that are presented as mean with range. Differences between means were analysed by twotailed t-test, one-way ANOVA followed by Tukey's post hoc test or twoway ANOVA followed by Tukey's or Sidak's post hoc test. The level of significance was set at p < 0.05.
Results
Effect of organ culture with LPS or Ang II on selected proinflammatory markers in mouse MRA and aorta segments. Secretion of IL-6 and MCP-1 from cultured mouse MRA ( fig. 1A ,B) and aorta ( fig. 1E ,F) segments was significantly increased in the presence of 100 ng/mL LPS, but not 10 nM Ang II. Furthermore, 24-hr organ culture with 100 ng/mL LPS, but not 10 nM Ang II, significantly induced the expression of VCAM-1 at the mRNA level in MRA segments ( fig. 1C) and at the protein level in aorta segments ( fig. 1G,I ) compared to artery segments cultured in media alone (Ctr). Endothelial nitric oxide synthase (eNOS) protein or mRNA (Nos3) expression was quite variable within the groups. There was no significant difference in eNOS and Nos3 expression between the groups of aorta and MRA segments, respectively ( fig. 1D ,H,I). Compared to fresh arteries, Nos2 mRNA expression tended to be increased in cultured mouse MRA, however not significantly (data not shown).
Effect of organ culture with or without LPS or Ang II on vasomotor responses of mouse MRA. In general, 24-hr organ culture of mouse MRA significantly attenuated vasoconstrictive responses to K-PSS compared to fresh artery segments. The presence of 100 ng/mL LPS in the culture media significantly diminished vasodilatory responsiveness of MRA to 10 lM carbachol compared to Ctr. Furthermore, MRA segments incubated with 100 ng/mL LPS tended to exhibit augmented resting tension in PSS compared to Ctr, however not significantly. There was no marked basal stretchinduced tone in any of the groups (data not shown). Compared to Ctr, the presence of 10 nM Ang II in the culturing media did not alter any of the basic vasomotor responses estimated (table 1) . PE induced a marked vasoconstriction of all the investigated mouse MRA. The presence of 100 ng/mL LPS and 10 nM Ang II in the culturing media attenuated PEinduced maximum response (E max , % of DT max ) compared to Ctr, although significance was only achieved with 10 nM Ang II ( fig. 2A and table 2 ). Cumulative concentration-response relations to Ang II in the four groups of isolated mouse MRA are shown in fig. 2B . Ang II induced a subtle bell-shaped response in all groups with significant variations in responsiveness between the individual artery segments. The Ang IIinduced concentration-response curves yielded non-converging logistic nonlinear regression, and hence, no pEC 50 and E max values could be estimated. Alternatively, AUC and maximal response between 10 and 100 nM Ang II were used to quantify the concentration-response curves (table 2) . Results showed that 24-hr organ culture of mouse MRA, in general, significantly reduced AUC for Ang II-induced concentrationresponse curves. Moreover, fig. 2B shows that organ culture of mouse MRA with 10 nM Ang II attenuated mouse MRA responsiveness to Ang II. Furthermore, organ culture of mouse MRA with increasing concentrations of Ang II (100 nM and 10 lM) appeared to concentration-dependently attenuate the vasomotor responses of MRA to Ang II ( fig. 2C ). However, significant differences were only achieved compared to fresh arteries due to the large variations in responsiveness between artery segments. Data are presented as mean AE S.E.M. with n = the number of artery segments and N = the number of animals. DT max = response to 'cocktail' expressed as baseline-subtracted tension, Ctr = organ culture alone, LPS = organ culture with 100 ng/mL LPS, Ang II = organ culture with 10 nM Ang II. Statistical analysis was performed with one-way ANOVA followed by Tukey's post hoc test, *p < 0.05 versus fresh, **p < 0.01 versus fresh and #p < 0.05 versus Ctr.
potent and efficacious vasoconstriction of human isolated SRA ( fig. 2D ).
Effect of organ culture on the expression of Agtr1a, Agtr1b and Tlr4 mRNA in mouse MRA.
Investigations of Ang II receptor subtype expression at the mRNA level in the four test groups of isolated mouse MRA revealed that all groups expressed Agtr1a and Agtr1b ( fig. 3A,   B ), while none expressed detectable Agtr2 (data not shown). Interestingly, 24-hr organ culture significantly attenuated Agtr1a mRNA expression across all cultured groups (~20-fold) compared to fresh arteries with no significant changes in Agtr1b mRNA expression. Furthermore, 24-hr organ culture significantly up-regulated mRNA expression of the LPS receptor Tlr4 (~2 times) in all cultured arteries compared to fresh arteries ( fig. 3C ). 
Data are presented as mean AE S.E.M., n = the number of artery segments and N = the number of animals. DT max = response to 'cocktail'. Ctr = organ culture alone, LPS = organ culture with 100 ng/mL LPS. AUC = area under the curve. Statistical analysis is performed with one-way ANOVA with Tukey's post hoc test, **p < 0.01 versus Ctr, #p < 0.05 versus fresh and ##p < 0.01 versus fresh. 
Concentration-and time-dependent effects of LPS, TNF-a,

Expression of Ang II receptor subtypes in HUVEC and HASMC.
Expression of the two human Ang II receptor subtypes AT 1 R and AT 2 R was evaluated at the mRNA level in treated and untreated HUVEC and HASMC. Firstly, in cultured HUVEC, there was no detectable mRNA expression of either AGTR1 (AT 1 R) or AGTR2 (AT 2 R) (data not shown). Secondly, cultured HASMC expressed AGTR1 mRNA ( fig. 8 ), while AGTR2 mRNA was not detectable (data not shown).
Although not significant, results indicated augmented AGTR1 mRNA expression after 24-hr exposure of HASMC to 100 ng/ mL TNF-a or 10 lg/mL LPS ( fig. 8 ).
Discussion
We studied the direct vascular pro-inflammatory effects of Ang II and LPS and concomitant changes in vascular function of mouse MRA. This vessel specimen was chosen due to the significant role of MRA in blood pressure and tissue perfusion regulation [27] . We found that contrary to the observed effects of LPS, culturing of mouse MRA and aorta segments for 24 hr with 10 nM Ang II did not induce any of the selected pro-inflammatory markers. The observed expression of eNOS/ Nos3 and Nos2 (iNOS) in the cultured arteries in our study is in line with previous studies in cultured rat aorta [28] . The absence of pro-inflammatory effects of Ang II is, at least for IL-6, inconsistent with previous findings in cultured mouse carotid arteries and thoracic aorta [19] . Yet, the concentration of Ang II and duration of exposure used might not be optimal to detect pro-inflammatory effects in the investigated vascular beds. By comparison, in vivo studies have shown that infusion of Ang II into rats resulting in a blood pressure in the normotensive range induced NF-jB activation in aorta and kidneys of rats as well as increased expression of IL-6 and MCP-1 in kidneys [29, 30] . In addition, in vivo administration of Ang II induced cellular adhesion molecule-dependent leucocyte adhesion in the mesenteric microcirculation of rats at physiologically relevant doses (1 nM) [31] [32] [33] .
Investigations of vascular function in the wire myograph showed that 24-hr organ culture of mouse MRA generally preserved artery viability and endothelium-dependent vasodilation in response to carbachol as previously described in rat MRA [34] . Responses to K-PSS were, however, significantly reduced after organ culture. This is in agreement with previous reports of reductions in VSMC contractility of rabbit superior mesenteric arteries cultured in the presence of FBS [35] . On the other hand, De Mey and colleagues did not observe any changes in responses to high K + solution in renal arteries cultured in serum-supplemented media [36] . Exposure to LPS significantly attenuated carbachol-induced vasodilation, indicating impaired endothelial function, in agreement with previous studies in various vessel specimens [37] [38] [39] [40] . Impaired responses to muscarinic receptor agonists could also be explained by loss of receptors or changes in downstream signalling such as eNOS [41] . However, eNOS/NOS3 expression was unchanged in the LPS-treated arteries in our study. Moreover, to our knowledge, there is no evidence of LPS-induced muscarinic receptor down-regulation ex vivo. Contrary to similar studies in cultured mouse carotid arteries [42] , 10 nM Ang II did not significantly affect endothelial function of mouse MRA. The reported direct detrimental effects of Ang II on endothelial function in mouse carotid arteries were suggested to be related, in large part, to superoxide-mediated reduction in NO bioavailability [42] . The inconsistency between our results and those described in carotid arteries could be related to differences in vascular bed. Studies in rat arteries have shown that as the vessel size decreases, the contribution of NO to endothelium-derived vasodilation decreases, while the importance of endothelium-derived hyperpolarizing factor (EDHF) increases [43] . In agreement, NO only plays a partial role in endothelium-dependent vasodilation of mouse mesenteric arteries in concert with prostanoids and EDHF [44] . The significantly attenuated maximal responses (E max ) of mouse MRA to PE observed after exposure to 10 nM Ang II could involve compensatory changes in adrenoceptor expression [45] or desensitization due to Ang II-induced noradrenaline release from sympathetic nerve endings [46] . This, however, requires further investigations. The subtle bell-shaped concentrationdependent vasomotor responses of mouse MRA to Ang II are in line with previous observations [21] . Human SRA, on the other hand, displayed high sensitivity and responsiveness to Ang II. These experiments thus served as positive controls of biological activity of the peptide preparations of Ang II and [Sar1]-Ang II. The observed differences in responsiveness to Ang II between mouse MRA and human SRA could involve varying receptor density or sensitivity to receptor desensitization and mechanisms behind this. The indications of impaired vasomotor responses of mouse MRA to Ang II after ex vivo exposure to Ang II might be explained by ligand-induced desensitization and/or internalization of AT 1 R, which decreases the available active receptors present on the cell surface and the associated signalling pathways [47, 48] . While ex vivo exposure to Ang II in our study impaired vasomotor responses of mouse MRA to both PE and Ang II, 10 nM Ang II did not affect vasomotor responses to the endothelin receptor type B (ET B R) agonist, sarafotoxin 6c (data not shown). Contrary to the contractile a 1 receptors and AT 1 R, which are predominantly expressed in VSMC, ET B R are expressed in both VSMC and EC exerting a dual action on vascular tone [49] , which may possibly explain these differences.
The transcriptional expression level of a certain receptor is not necessarily correlated with the protein level of the receptor or its activity [50] . Nevertheless, the observed suppression of Agtr1a mRNA expression after culture as previously described in rat mesenteric arteries [51] and opposite augmentation of Tlr4 mRNA expression might, at least to some degree, explain the dissimilarities in vascular pro-inflammatory effects of LPS and Ang II. Furthermore, the putative anti-inflammatory role of AT 2 R [52] could potentially mask the pro-inflammatory effects of Ang II via AT 1 R. However, we were not able to detect transcriptional expression of Agtr2 in mouse MRA. Studies have shown that AT 1A R expression is necessary for Ang II-induced vasoconstriction of mouse mesenteric arteries [53] . In this regard, the maintained ability of cultured mouse MRA to constrict in response to Ang II, albeit at lower magnitude, indicates that functional AT 1A R are still present after culturing. Transcriptional regulation of AT 1 R expression by mechanical cues has previously been described in cultured rat mesangial cells [54] and mouse podocytes [55] . Cultured arteries are usually free from the mechanical stresses that are constantly acting on the vascular wall in vivo [56] . Hence, we speculate that the mechanisms responsible for the observed suppression of Agtr1a mRNA could involve the absence of stretch-induced AT 1 R expression [57] . The augmented Tlr4 mRNA expression observed in cultured mouse MRA is in agreement with reports of low shear stress-induced up-regulation of TLR4 expression [58] .
Based on the previous studies mentioned in the Introduction [13] [14] [15] [16] [17] , investigations in primary human EC and VSMC would allow us to further elucidate the possible concentration-and time-dependent effects of Ang II on proinflammatory markers. To rule out the possibility of enzymatic degradation of Ang II by angiotensinase A [59] , we included the stable analogue [Sar1]-Ang II in our studies. Results showed unexpectedly that, contrary to LPS and TNF-a, Ang II and [Sar1]-Ang II did not induce secretion or mRNA expression of IL-6 or MCP-1 in HUVEC or HASMC. Furthermore, in terms of NOS3 and VCAM1 mRNA expression, the only significant finding was TNF-ainduced down-regulation of NOS3 in HUVEC, which is in line with previous reports [60] . Moreover, while TNF-a induced time-and concentration-dependent activation of NFjB (p65) in HUVEC and HASMC, Ang II and [Sar1]-Ang II had no significant effects, even at supraphysiological concentrations. Explanations for the inconsistencies between our findings and those described in the literature are unknown. Yet, uncertainties about the specificity of previously described effects of Ang II in cultured cells exist in terms of possible endotoxin contamination of the investigated peptide preparations which we excluded. We would have expected LPS to activate NF-jB (p65) in both HUVEC [61] and HASMC [62] . Mako et al. [63] studied activation of NF-jB in HUVEC in terms of nuclear translocation and showed that, compared to TNF-a, LPS induced a slower onset and smaller maximum effect peaking at 120 min. The serum starvation step, which was only performed for the analysis of NF-jB (p65) phosphorylation, might have decreased the effect of LPS due to low levels of soluble CD14 and LPS-binding protein [64, 65] . In addition to the putative direct pro-inflammatory effects of Ang II on its own, a more indirect or modulatory role of Ang II has been proposed through crosstalk with well-known proinflammatory inducers [20, 25, 66, 67] . Based on studies suggesting an augmenting effect of Ang II on TLR4 expression and the LPS-TLR4 signalling pathway in various cell types [25, 68] , we investigated the possible synergistic effect of [60] . Therefore, the discrepancies between our findings and the literature on Ang II receptor expression could perhaps be explained by variability in cell donor, vendor, culturing conditions, etc. [71] . Meanwhile, in agreement with Bkaily et al.
[72], we found that our cultured HASMC significantly expressed AT 1 R, but not AT 2 R. Contrary to reports of proinflammatory effects of Ang II in cultured rat VSMC [15] [16] [17] and human saphenous vein VSMC [73] , our negative findings in HASMC are supported by studies in rat aortic smooth muscle cells by Jiang et al. [18] . As mentioned, heterogeneity in cultured human primary cells might explain these discrepancies [74] . Ang II-induced AT 1 R desensitization and internalization might also play a role in the absence of responses to Ang II in HASMC [72] . Conversely, exposure of HASMC to LPS and TNF-a indicated a possible augmenting effect on AT 1 R mRNA expression. Similar observations have been made in rat aortic smooth muscle cells in response to LPS [75] and neonatal rat cardiac fibroblasts in response to TNF-a [76] . From our study, these findings are the sole indications of a pro-inflammatory role of Ang II in vitro. The results support the putative synergism between the vasoactive agent Ang II and well-known pro-inflammatory inducers (LPS and TNF-a) and warrant further investigations. Based on our findings, we suggest that the absence of vascular pro-inflammatory responses to Ang II ex vivo and in vitro could be due to suppression of expression or desensitization/internalization of AT 1 R during culture. In the end, the putative direct pro-inflammatory role of Ang II in the vascular wall depends on the expression of AT 1 R in vivo. To maintain or mimic in vivo AT 1 R expression in isolated tissue, one strategy could be to apply controlled stretch or pressure under culture. This might, however, induce a confounding factor by stretch-induced ligand-independent activation of AT 1 R [77] . Another strategy could, based on our results shown in cultured VSMC, be to pre-incubate with prototypical pro-inflammatory inducers and thereby possibly up-regulate AT 1 R expression.
In summary, our results showed that exposure of mouse MRA and aorta segments to LPS during culture induced expression of VCAM-1 and secretion of IL-6 and MCP-1 in addition to impaired endothelial function of mouse MRA. Moreover, LPS and TNF-a concentration-dependently stimulated IL-6 and MCP-1 secretion from cultured HUVEC and HASMC. On the other hand, we could not demonstrate or reproduce the putative direct pro-inflammatory effects of Ang II in cultured mouse MRA and aorta segments or HUVEC and HASMC. Yet, exposure of mouse MRA to Ang II in culture tended to reduce vasomotor responses to phenylephrine and Ang II. The present findings have important implications, because they firstly highlight difficulties existing when removing vascular tissue from its microenvironment. Secondly, the results of our study challenge the growing body of evidence from ex vivo and in vitro studies suggesting a direct proinflammatory role of Ang II in the vascular wall. Further investigations will aid in establishing the translational value of our findings with regard to the in vivo situation.
